Target intelligence / Profile preview

E74-like ETS transcription factor 4 (ELF4) (ELF4)

Target
ELF4
Molecular classification
Transcription factor, ETS family, ELF subfamily
01

Overview

E74-like ETS transcription factor 4 (ELF4), also known as Myeloid Elf-1-like factor (MEF), is a member of the ETS family of transcription factors that regulates gene expression by binding to specific DNA sequences. It is a key regulator of the cell cycle, particularly the G1/S transition, and is vital for the development and function of immune cells such as natural killer (NK) and T cells. ELF4 also plays a significant role in maintaining hematopoietic stem cell quiescence and modulating the innate immune response through the induction of type I interferons. In human disease, ELF4 is frequently dysregulated; it is overexpressed in several malignancies, including glioma, colorectal cancer, and leukemia, where it promotes tumor growth, metastasis, and resistance to therapy. Conversely, it can act as a tumor suppressor in certain epithelial contexts, highlighting its complex, context-dependent role in carcinogenesis. Although direct pharmacological inhibitors of ELF4 are not yet clinically available, it is an active area of research for targeted cancer therapies and immunomodulation.

Other names
Myeloid Elf-1-like factorMEFE74-like factor 4ETS-related transcription factor Elf-4
02

Mechanism of action

Transcriptional modulation of target genes involved in cell cycle progression and immune cell development

03

Biological functions

Cell cycle regulationHematopoiesisImmune responseApoptosis regulationDNA damage responseStem cell quiescenceTranscriptional activation
04

Disease associations

CancerLeukemiaLymphomaGliomaColorectal cancerEndometrial cancerInflammationViral infection
05

Safety considerations

Potential for impaired immune functionDisruption of normal hematopoiesisContext-dependent tumor-suppressive vs. oncogenic roles
06

Interacting drugs

(R)-STU104

3 more in the full profile.

07

Biomarkers

ELF4 mRNA expressionELF4 protein levelsELF4 gene amplificationELF4-AML1 fusionELF4-ERG fusion

Beyond the preview

Go deeper on E74-like ETS transcription factor 4 (ELF4) (ELF4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on E74-like ETS transcription factor 4 (ELF4) (ELF4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call